PN and PDRN are not identical
Polynucleotides, often shortened to PN, and polydeoxyribonucleotide, or PDRN, are related DNA-derived materials. The terms are sometimes used loosely in marketing, although the products and their proposed effects differ.
Promising findings have limits
A 2026 scientific commentary on female pattern hair loss describes a small PDRN study involving 40 women. It highlights limited follow-up evidence and the difficulty of drawing firm conclusions from a comparison of PDRN alone with PDRN plus platelet-rich plasma.
The authors distinguish PDRN from PN and call for further research. These findings do not establish that every polynucleotide product, injection protocol or type of hair loss will respond in the same way.
What to ask before considering treatment
Ask for the exact product name, the evidence for your diagnosis, likely risks, alternatives, the full course cost and the follow-up plan. Ask how any change will be measured and what happens if you see no improvement.
Start with a diagnosis rather than a product. Established options and the choice not to have treatment should be part of an informed discussion. This page does not confirm current clinic availability or promise a particular result.
Sources and further reading
This article provides general information and does not replace an individual medical assessment, diagnosis or treatment recommendation.